Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
122.97-0.03 (-0.02%)
At close: 04:00PM EDT
121.10 -1.87 (-1.52%)
After hours: 04:33PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Performance Outlook
Previous Close123.00
Open124.35
Bid121.10 x 900
Ask125.00 x 1300
Day's Range122.59 - 125.16
52 Week Range117.08 - 189.07
Volume617,475
Avg. Volume688,423
Market Cap29.635B
Beta (5Y Monthly)N/A
PE Ratio (TTM)3.03
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 02, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BNTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioNTech SE
    Analyst Report: BioNTech SEBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • Insider Monkey

    12 Most Promising Healthcare Stocks According to Analysts

    In this article, we will take a look at the 12 most promising healthcare stocks according to analysts. To see more such companies, go directly to 5 Most Promising Healthcare Stocks According to Analysts. 2023 is turning out to be a horrific year for financial markets as investors are starting to see a glimpse of […]

  • Insider Monkey

    12 Cheap Healthcare Stocks to Buy in 2023

    In this piece, we will take a look at the twelve cheap healthcare stocks to buy in 2023. For more healthcare stocks, head on over to 5 Cheap Healthcare Stocks to Buy in 2023. The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades. Modern […]

  • Zacks

    Wynn Resorts and BioNTech have been highlighted as Zacks Bull and Bear of the Day

    Wynn Resorts and BioNTech have been highlighted as Zacks Bull and Bear of the Day.

Advertisement
Advertisement